One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1136/annrheumdis-2014-eular.5656
Copy DOI Journal: Annals of the Rheumatic Diseases |  Publication Date: Jun 1, 2014 |
 Citations: 2 |
Affiliation: Metroplex Clinical Research Center, Oregon Health & Science University, University of Paris-Sud, Institut Polytechnique de Paris, University of Occupational and Environmental Health Japan, Universität Hamburg, Seoul National University, University of California, Los Angeles, University of Queensland, Pfizer (United States), University of Alabama at Birmingham, Pfizer (Australia)BackgroundTofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). Phase (P) 2, P3, and open-label long-term extension (LTE) studies described the safety profile of...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
